Featured Events Staging

csam conference featured events

Hepatitis C in Primary Care and Drug and Alcohol Settings Workshop »

Wednesday, November 2, 2022
9:00 a.m. to 12:30 p.m.

HCV Intervention Implementation Symposia »

Wednesday, November 2, 2022
1:30 p.m. to 5:30 p.m.

Fundamentals of Addiction Medicine »

Sunday, November 6, 2022
10:00 a.m. to 6:00 p.m.

Hepatitis C in Primary Care and Drug and Alcohol Settings Workshop

Wednesday, November 2, 2022
9:00 a.m. to 12:30 p.m.

Delivered by facilitators from:

People who inject drugs (PWID) represent approximately 90% of newly acquired hepatitis C (HCV) infections. Clinicians working with PWID play an important role in reducing HCV-related morbidity and mortality through early diagnosis and treatment. With the advent of well-tolerated, short-course direct acting antiviral HCV regimens with cure rates over 95%, there is an opportunity to vastly improve the health outcomes of people living with HCV.

This course is designed for medical practitioners, nurses, addiction medicine specialists and other clinical staff working with people who inject drugs. Through this full-day training, participants will gain the skills to confidently manage hepatitis C in their setting.

  • Describe the risk factors for HCV infection, enabling effective screening and prevention education
  • Demonstrate competence conducting and interpreting tests to diagnose HCV
  • Recognise risk factors, clinical signs, symptoms and complications of liver disease
  • Demonstrate understanding of Direct Acting Antiviral therapy for the treatment of HCV and competence in selecting appropriate therapy
  • Describe recommended on-treatment monitoring and post-treatment follow up protocols
Time
Session
9:00 a.m.
Hepatitis C in Primary Care and Drug and Alcohol Settings Workshop
10:15 a.m.
Break
10:25 a.m.
Hepatitis C in Primary Care and Drug and Alcohol Settings Workshop (continued)
12:30 p.m.
Workshop close & lunch

HCV Intervention Implementation Symposia

Wednesday, November 2, 2022
1:30 p.m. to 5:30 p.m.

Delivered by facilitators from:

Building on INHSU’s highly successful education and knowledge exchange initiatives, this session focuses on advanced implementation. It is the first program of its kind to provide practitioners with detailed information on effective interventions to enhance the HCV care cascade in a practical and accessible way.

The symposia will showcase good practice interventions and models of care in different settings, highlighting key research, challenges and learnings in a collaborative coaching environment, with the aim of supporting participants to develop or enhance their own HCV models of care. The program will focus on practical implementation of evidence-based interventions such as point-of-care testing, dried blood spot testing, peer support, patient navigation and case finding.

This course is intended for anyone interested in implementing or scaling up HCV interventions in their service setting, including healthcare providers, community members and policy makers from a variety of local settings, such as primary care, corrections, outreach, homelessness, mental health, needle and syringe services and health departments.

  • Understand evidence-based interventions demonstrated to enhance the HCV care cascade
  • Describe how a range of interventions work and how they can be implemented to enhance models of HCV care
  • Understand the HCV care cascade and be able to identify areas for enhancement in service delivery
  • Identify suitable interventions to enhance service delivery
  • Analyze barriers of implementing successful interventions and how to overcome them
Time
Session
1:30 p.m.
Hepatitis C Intervention Implementation Symposia
3:00 p.m
Break
3:15 p.m.
Hepatitis C Intervention Implementation Symposia (continued)
5:15 p.m.
Thank you and Symposia Close
5:30 p.m.
Networking

Recognizing and Responding to Intimate Partner Violence in Clinical Encounters

Thursday, November 3, 2022
2:00 p.m. to 5:00 p.m.

Delivered in partnership with the College of Physicians and Surgeons of Saskatchewan
College of Physicians and Surgeons of Saskatchewan logo

Substance use is a risk factor for intimate partner violence (IPV), both by perpetrators and for victims. In this three-hour course, attendees will gain a fuller understanding of the prevalence of IPV in Canada and its overlap with other forms of family violence, as well as signs, symptoms, risk and protective factors. Attendees will learn principles and strategies for trauma- and violence-informed care for clinical encounters with patients or clients affected by IPV. Attendees will also learn evidence-based approaches for safely recognizing and responding to IPV and children’s exposure to IPV in clinical encounters. The course will include experiential activities to reinforce learning, including role play, videos for discussion and reflection questions.

The VEGA (Violence, Evidence, Guidance, and Action) Project logoDeveloped and delivered by McMaster University’s Violence, Evidence, Guidance and Action Project — The VEGA Project — this course is a pan-Canadian, evidence-based guidance and education resource developed to assist healthcare and social service providers in recognizing and responding safely to family violence. Enhance your skills in assessing for IPV and confidence in supporting clients who disclose IPV. Advance registration required, as attendance is limited to 40. Suitable for all health care professionals.

Funded by the Public Health Agency of Canada, the VEGA team developed these resources in collaboration with expert consultants and organizations, 22 national organizations and other stakeholders.

  • Describe the prevalence of intimate partner violence (IPV) among the general Canadian population and those who use substances.
  • Describe IPV’s overlap with other forms of family violence, as well as it’s impact, risk and protective factors, signs, and symptoms.
  • Understand principles and strategies for trauma- and violence-informed care for clinical encounters with patients or clients who have experienced exposure to IPV.
  • Articulate and apply evidence-based approaches for safely recognizing and responding to IPV and children’s exposure to IPV in clinical encounters.
  1. Brief epidemiology of family violence including child maltreatment and intimate partner violence (IPV); definitions, prevalence, risk and protective factors
  2. Discussion of relationship of IPV to substance use
  3. Introduction to VEGA (Violence, Evidence, Guidance, Action) Resources including modules on Creating Safety
  4. Discussion of trauma-informed and trauma- and violence-informed care
  5. IPV care pathway to assist healthcare providers in interacting with patients experiencing IPV
  6. Recognizing IPV including signs and symptoms
  7. Principles for safe inquiry about IPV including limits of confidentiality
  8. Principles for safe response to a disclosure of IPV
  9. Assessing risk of immediate danger
  10. Safety planning and strategies
  11. Determining appropriate resources and referrals
  12. Documentation
  13. Considering children’s exposure to IPV
  14. Interactions with those at risk of and/or committing IPV

Dr. Harriet MacMillan
VEGA Project Lead, Distinguished University Professor, in the Department of Psychiatry and Behavioural Neurosciences at McMaster University, family violence researcher, pediatrician and psychiatrist at Hamilton Health Sciences Centre.

Dr. Melissa Kimber
Assistant Professor, Psychiatry and Behavioural Neurosciences, McMaster University

Dr. Anne Niec
Professor, Department of Pediatrics, McMaster University

Fundamentals of Addiction Medicine

Sunday, November 6, 2022
10:00 a.m. to 6:00 p.m.

The CSAM-SMCA Fundamentals of Addiction Course provides early-career clinicians and students with a solid foundation for continued learning in addictions care and treatment. The course will be offered in-person at our 2022 conference. You can register for Fundamentals when you register for the conference!

CSAM-SMCA fundamentals